Nomura Holdings, Inc.

NYSE:NMR

Financial - Capital Markets

Financial Services
$9.23 -1.32%

-$0.12 today

Market cap
$27.29B
Beta
0.61
P/E (TTM)
0.3
EPS (TTM)
$4,986.67
Dividend yield
3.55%
52W Low $6.02High $9.58

Volume 3.51M

Average 1.75M

NMR Revenue

Total income from selling goods and services before any costs are deducted; the top line of the income statement.

Nomura Holdings, Inc.NYSE: NMR

Revenue · Q1 FY2027 · quarter ended Jun 2026

Revenue declines year over year

Q1 FY2027 revenue of ¥686.71B fell 38.2% year over year, behind the -2.4% change in trailing-twelve-month revenue. Sequentially, it fell 49.5% from the prior quarter. Over 3 fiscal years it compounded at +27.5% a year.

Context

  • Revenue increased in 3 of the last 3 fiscal years.
  • FY2026 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether revenue reaches the consensus estimate from 2 analysts of ¥2.48T (-47.9%) for the fiscal year ending Mar 2027, a slowdown from the +5.6% reported in FY2026.

Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.

Latest quarterJun 2026
¥686.71B-49.5% QoQ
Last fiscal yearMar 2026
¥4.76T+5.6% YoY
LTMJun 2026
¥4.33T-2.4% YoY
Revenue past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-38.2%——
1 year+5.6%-47.9%-53.5 pp
3-year CAGR+27.5%-18.8%-46.3 pp
5-year CAGR-10.1%—
10-year CAGR——

Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.

Revenue history

JPY · from the income statement

Latest · FY2026
4.76T JPY
Year-over-year change
+5.6%
4-year CAGR
+36.4%
Reported Analyst consensus estimate Further estimates hidden. Sign in to unlock

Revenue vs competitors

How NMR compares with its peers on the latest reported figures

  • Peers report in different currencies, so revenue is compared through growth and rates rather than absolute size.
  • Its year-over-year change of -2.4% is the 8th highest of 9, against a peer median of +13.0%.
  • Over three fiscal years its annual growth of +27.5% compares with a peer median of +14.3%.
NMR Competitors
Revenue for NMR and competitors
Company Period LTM YoY 3-year CAGR
NMRNomura Holdings, Inc.LTM Jun 2026¥4.33T JPY-2.4%+27.5%
MSMorgan StanleyLTM Sep 2026$129.76B USD+15.7%+22.5%
GSThe Goldman Sachs Group, Inc.LTM Sep 2026$123.49B USD-2.9%+22.1%
UBSUBS Group AGLTM Jun 2026$76.03B USD+5.6%+26.1%
JEFJefferies Financial Group Inc.LTM Aug 2026$12.46B USD+16.2%+14.8%
SFStifel Financial Corp.LTM Sep 2026$6.69B USD+9.3%+11.6%
EVREvercore Inc.LTM Jun 2026$4.74B USD+45.7%+11.8%
LAZLazard LtdLTM Sep 2026$3.37B USD+10.3%+4.1%
OPYOppenheimer Holdings Inc.LTM Mar 2026$1.72B USD+18.5%+13.8%
Peer median (excluding NMR) —+13.0%+14.3%

Competitors are the stored peer set for NMR. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

JPY
Metric
FY2022
Mar 2022
FY2023
Mar 2023
FY2024
Mar 2024
FY2025
Mar 2025
FY2026
Mar 2026
Revenue1.37T2.3T3.97T4.51T4.76T
Cost of Revenue230.11B1.15T2.6T2.84T2.59T
Gross Profit1.14T1.14T1.38T1.66T2.17T
Gross Margin83.3%49.9%34.7%36.9%45.6%
Research & Development00000
Selling, General & Admin529.51B605.79B673.52B732.39B1.37T
Operating Expenses917.09B995.5B1.1T1.19T1.63T
Depreciation & Amortization59.52B61.42B61.34B61.65B68.27B
EBITDA286.15B210.9B335.19B533.62B608.09B
EBITDA Margin20.8%9.2%8.4%11.8%12.8%
Operating Income226.62B149.47B273.85B471.96B539.82B
Operating Margin16.5%6.5%6.9%10.5%11.3%
Interest Income284.22B1.11T2.62T2.93T2.67T
Interest Expense230.11B1.15T2.6T2.84T2.59T
Other Income / Expenses00000
Income Before Tax226.62B149.47B273.85B471.96B539.82B
Pre-Tax Margin16.5%6.5%6.9%10.5%11.3%
Income Tax Expense80.09B57.8B96.63B124.71B165.44B
Net Income143B92.79B165.86B340.74B362.13B
Net Margin10.4%4.0%4.2%7.6%7.6%
EPS (Basic)46.6830.8654.97115.30123.08
EPS (Diluted)45.2329.7452.75111.03118.99
Weighted Avg Shares3.06B3.01B3.02B2.96B2.94B
Weighted Avg Shares (Diluted)3.16B3.11B3.14B3.07B3.04B

Nomura Holdings, Inc.

NYSE:NMR

Intrinsic Alpha fair value

Locked

Current Price

$9.23

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.